-
ECONOMIC IMPACT OF INTRODUCING PCV20 IN COLOMBIAN PEDIATRIC POPULATION: A COST UTILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
BARRIERS TO HEALTHCARE USE AMONG ADOLESCENTS IN CONFLICT-AFFECTED IDP CAMPS IN NORTHEASTERN NIGERIA: REAL-WORLD EVIDENCE ON ACCESS, EQUITY, AND SERVICE DELIVERY COSTS
Feb 25, 2026, 14:41 PM -
CHARACTERISTICS AND COMORBIDITIES INFLUENCING MORTALITY RISK AMONG PATIENTS WITH HEREDITARY ANGIOEDEMA
Feb 25, 2026, 14:41 PM -
BLINATUMOMAB FOR FIRST RELAPSE OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER AMBISPECTIVE COHORT STUDY FROM CARTAGENA, COLOMBIA
Feb 25, 2026, 14:41 PM -
IDENTIFYING TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN SECONDARY DATA: METHODOLOGICAL CHALLENGES, EMERGING OPPORTUNITIES, AND FUTURE DIRECTIONS
Feb 25, 2026, 14:41 PM -
USING THE DELPHI METHOD TO IDENTIFY EVIDENCE GAPS IN SUPPORT OF HTA SUBMISSIONS FOR RARE PEDIATRIC CONDITIONS: A CASE STUDY IN NON-DYSTROPHIC MYOTONIAS
Feb 25, 2026, 14:41 PM -
BUDGET IMPACT ANALYSIS OF SONPIRETIGENE ISTEPARVOVEC FOR RETINITIS PIGMENTOSA WITH SEVERE VISION LOSS
Feb 25, 2026, 14:41 PM -
HOSPITAL LENGTH OF STAY AMONG MEDICARE BENEFICIARIES UNDERGOING TRANSCAROTID ARTERY REVASCULARIZATION VERSUS CAROTID ENDARTERECTOMY: A RETROSPECTIVE CLAIMS ANALYSIS
Feb 25, 2026, 14:41 PM -
REAL-WORLD DEL(17P), TP53, AND IGHV BASELINE TESTING PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHIN A LARGE NETWORK OF US COMMUNITY ONCOLOGY PRACTICES
Feb 25, 2026, 14:41 PM -
BORROWING STRENGTH WITHOUT BORROWING BIAS IN ONCOLOGY USING POWER PRIORS AND COMMENSURATE PRIORS FOR LONG TERM OVERALL SURVIVAL EXTRAPOLATION
Feb 25, 2026, 14:41 PM -
UNDERSTANDING HYPERTENSION IN YOUNG ADULTS: DIAGNOSIS TIMING, TIME WITHIN TARGET RANGE, AND BLOOD PRESSURE TRAJECTORIES
Feb 25, 2026, 14:41 PM -
UNDERSTANDING PERSPECTIVES, BARRIERS AND ENABLERS FOR CLINICAL TRIAL PARTICIPATION IN REPRESENTATIVE PATIENT POPULATIONS
Feb 25, 2026, 14:41 PM -
DOES BRAND-TO-BRAND COMPETITION REDUCE PRICES OF PRESCRIPTION DRUGS?
Feb 25, 2026, 14:41 PM -
SPILLOVER EFFECTS OF US MFN POLICY ON EUROPEAN DRUG ACCESS
Feb 25, 2026, 14:41 PM -
QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA
Feb 25, 2026, 14:41 PM -
THE ECONOMIC IMPACT OF METABOLIC SYNDROME IN SCHIZOPHRENIA: A CLAIMS-BASED ANALYSIS IN THE UNITED STATES
Feb 25, 2026, 14:41 PM -
COST ANALYSIS AND HEALTHCARE RESOURCE UTILIZATION AFTER OPEN LIVER RESECTION FROM A RANDOMIZED CONTROL TRIAL
Feb 25, 2026, 14:41 PM -
HEALTH UTILITY VALUES AMONG MIDDLE-AGED AND OLDER ADULTS ACROSS SEVEN MAJOR GEOGRAPHICAL REGIONS IN CHINA: EVIDENCE FROM CHARLS 2020
Feb 25, 2026, 14:41 PM -
SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Feb 25, 2026, 14:41 PM -
EVALUATION AND VALIDATION OF A NOVEL POISON SEVERITY AND MORTALITY SCALE: A PILOT STUDY
Feb 25, 2026, 14:41 PM
